MPP consultation statement to EU pharmaceuticals legislation

BioMarin Pharmaceutical Inc. joins the MPP

We are delighted to announce our newest member: BioMarin Pharmaceutical. BioMarin Pharmaceutical joins its voice to the Medtech & Pharma Platform (MPP) Association, the leading European cross-sectoral industry association focused on combined products. The MPP...
MPP consultation statement to EU pharmaceuticals legislation

AbbVie joins the MPP

We are proud to welcome AbbVie as the newest member of the Medtech & Pharma Platform Association (MPP). AbbVie’s membership will reinforce MPP as the leading European cross-sectoral industry association, aiming to foster synergies between the medtech, pharma and...
MPP consultation statement to EU pharmaceuticals legislation

Outcome of the MPP 2023 General Assembly

The Medtech & Pharma Platform (MPP) Association held its annual General Assembly meeting on 5 April 2023. The MPP Secretariat presented an overview of the association activities in 2022 and an outlook for 2023 to the members. The MPP President underlined the...